Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Walgreens Boots Alliance (WBA) : "I can't take that risk anymore. "

Snap (SNAP) : "No, I need to wait and see on this one."

Teva Pharmaceuticals (TEVA) : "If you want to buy, I'd wait for Allergan (AGN) to sell its stake, but I'm not that crazy about it."

AT&T (T) : "I think it's a buy. I like all the changes they're making."

Seattle Genetics (SGEN) : "I want to own this stock."

Benchmark Electronics (BHE) : "It has a lot of cool devices. It's not cheap but I like it."

Over on Real Money, Cramer says Equifax (EFX) should have slammed the selling window shut. Get his insights with a free trial subscription to Real Money.

Cramer and the AAP team have updates on a few names in their portfolio. Find out what they're telling their investment club members about Pepsico (PEP) and Broadcom (AVGO) and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in PEP, AVGO, AGN.